Request Trial
shutterstock_1997869478_pla2na
Pla2na / Shutterstock.com
7 April 2022Sarah Gibbs

G 2/21: how to support inventive steps in patentability

Post-published evidence can be crucial to establishing patentability. G 2/21, the European Patent Office (EPO)’s referral to the Enlarged Board of Appeal (EBA) on the question of whether post-published evidence can be used to support the concept of “inventive step”.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026   The two major medical device makers are clashing over Atraverse’s Hotwire system, with Boston Scientific claiming the product infringes its patented radiofrequency transseptal-access technology, used in heart surgery.
Careers
Brazilian firm appoints patent strategist to lead department
12 October 2026   Ouro Preto Paranhos has brought in a licensed pharmacist with more than 26 years of intellectual property experience to lead the patent practice at the Rio de Janeiro firm.
Regulation & Industry
AIPPI World Congress: ‘Diversity need not be an obstacle to unity’
9 October 2026   As the AIPPI World Congress returned to Germany for the first time in nearly half a century, it heard calls for greater international cooperation and legal harmonisation, highlighting why diversity matters for the future of IP and brand owners.


Editor's picks

Boston Scientific expands dispute with J&J unit over cardiac-access technology
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026

Editor's picks

MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026
In-house counsel
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
1 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026
Pharma
Takeda sees off UK challenge to Elvanse SPC
28 September 2026
Pharma
Behind the case: How Novartis defended its blockbuster Entresto in the UK
22 September 2026
Regulation & Industry
Inside the deal boom: LSIPR’s five-part M&A series—all in one place
17 September 2026

More features

Brazilian firm appoints patent strategist to lead department
Fish & Richardson nets patent litigator to grow European practice
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
5 LSPN takeaways: What’s keeping Europe’s IP teams on their toes?
Beyond the primary patent: How pharma can build competitive barriers
Patent lawyers and judges discuss lofty UPC issues in grand London venue
Abbott clinches 18-country PI in glucose monitoring feud
G 1/25: EPO settles controversial patent description question